Single Dose LY2484595 Tablet Formulations to Determine the Impact of Dose Level, Food, and Ethnicity on the Pharmacokinetics in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 13 Jan 2012
At a glance
- Drugs Evacetrapib (Primary)
- Indications Atherosclerosis; Dyslipidaemias
- Focus Pharmacokinetics
- 13 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Oct 2011 Additional trial location (USA) identified as reported by ClinicalTrials.gov.
- 26 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.